Projects funded by the NCN
Specific interactions of new antitumor unsymmetrical bisacridines, UAs, with DNA and ABC proteins and their potential to modulate the enzymatic activity and transcription of nuclear receptors as the elements of their molecular mechanism of action.
2019/33/B/NZ7/02534
Keywords:
antitumor bisacridines UAs drug-DNA interactions ABC proteins transcriptional effect of drugs antitumor drug metabolism nuclear receptors urine and blood metabolites.
Descriptors:
- NZ1_2: Biochemistry
- NZ3_1: Cell biology
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Politechnika Gdańska
woj. pomorskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 10
Call: OPUS 17 - announced on 2019-03-15
Amount awarded: 3 011 720 PLN
Project start date (Y-m-d): 2020-04-02
Project end date (Y-m-d): 2023-04-01
Project duration:: 36 months (the same as in the proposal)
Project status: Project completed
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.